Strontium ranelate and risk of vertebral fractures in frail osteoporotic women

Bone

Volumn 48, Issue 2, 2011, Pages 332-338

  Rolland, Yves ^a,b   Van Kan, Gabor Abellan ^a,b   Gillette Guyonnet, Sophie ^a,b   Roux, Christian ^c   Boonen, Steven ^d   Vellas, Bruno ^a,b  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b CHU PURPAN   (France)

^c Hôpital Cochin ^*  (France)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Frailty; Risk reduction; Strontium ranelate; Vertebral fracture

Indexed keywords

PLACEBO; STRONTIUM RANELATE;

AGED; ARTICLE; BONE DISEASE; CONNECTIVE TISSUE DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FRAGILITY FRACTURE; FRAIL ELDERLY; GASTROINTESTINAL DISEASE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; POSTMENOPAUSE OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; TREATMENT DURATION; VASCULAR DISEASE; VERTEBRA FRACTURE;

AGED; AGED, 80 AND OVER; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; FEMALE; HUMANS; MALE; ORGANOMETALLIC COMPOUNDS; OSTEOPOROSIS; SPINAL FRACTURES; THIOPHENES;

EID: 78650989493     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.08.022     Document Type: Article

References (26)

1. Fried L.P., Tangen C.M., Walston J., Newman A.B., Hirsch C.., Gottdiener J., et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56:146-156.
2. Rockwood K., Stadnyk K., MacKnight C., McDowell I., Hebert R., Hogan D.B. A brief clinical instrument to classify frailty in elderly people. Lancet 1999, 353:205-206.
3. Ensrud K.E., Ewing S.K., Taylor B.C., Fink H.A., Stone K.L., Cauley J.A., et al. Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med Sci 2007, 62:744-751.
4. Seeman E., Vellas B., Benhamou C., Aquino J.P., Semler J., Kaufman J.M., et al. Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res 2006, 21:1113-1120.
5. Kanis J.A., Burlet N., Cooper C., Delmas P.D., Reginster J.Y, Borgstrom F., et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008, 19:399-428.
6. Parikh S., Mogun H., Avorn J., Solomon D.H. Osteoporosis medication use in nursing home patients with fractures in 1 US state. Arch Intern Med 2008, 168:1111-1115.
7. Inderjeeth C.A., Foo A.C., Lai M.M., Glendenning P. Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence. Bone 2009, 44:744-751.
8. Sambrook P.N., Cameron I.D., Chen J.S., Cumming R.G., Lord S.R., March L.M. Influence of fall related factors and bone strength on fracture risk in the frail elderly. Osteoporos Int 2007, 18:603-610.
9. Rolland Y., Abellan van Kan G., Bénétos A., Blain H., Bonnefoy M., Chassagne P., et al. Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. J Nutr Health Aging 2008, 12:335-346.
10. Suh T.T., Lyles K.W. Osteoporosis considerations in the frail elderly. Curr Opin Rheumatol 2003, 15:481-486.
11. Gold D.T. Osteoporosis and quality of life psychosocial outcomes and interventions for individual patients. Clin Geriatr Med 2003, 19:271-280.
12. Martin A.R., Sornay-Rendu E., Chandler J.M., Duboeuf F., Girman C.J., Delmas P.D. The impact of osteoporosis on quality-of-life: the OFELY cohort. Bone 2002, 31:32-36.
13. Meunier P.J., Roux C., Seeman E., Ortolani S., Badurski J.E., Spector T.D. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 2004, 350:459-468.
14. Reginster J.Y., Seeman E., De Vernejoul M.C., Adami S., Compston J., Phenekos C., et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 2005, 90:2816-2822.
15. Genant H.K., Wu C.Y., van Kuijk C., Nevitt M.C. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993, 8:1137-1148.
16. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30:473-483.
17. Looker A.C., Wahner H.W., Dunn W.L., Calvo M.S., Harris T.B., Heyse S.P., et al. Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 1998, 8:468-489.
18. Reginster J.Y., Janssen C., Deroisy R., Zegels B., Albert A., Franchimont P. Bone mineral density of the spine and the hip measured with dual energy X-ray absorptiometry: normal range and fracture threshold for western European (Belgian) postmenopausal females. Clin Rheumatol 1995, 14:68-75.
19. Slosman D., Provvedini D.M., Meunier P.J., Delmas P.D., Sebert J.L., De Vernejoul M.C. The use of different dual X-ray absorptiometry brands in a multicenter clinical trial. J Clin Densitom 1999, 2:37-44.
20. Heaney R.P., Zizic T.M., Fogelman I., Oszynski W.P., Geusens P., Kasibhatla C., et al. Risedronate reduces the risk of first vertebral fracture in osteoporotic women. Osteoporos Int 2002, 13:501-505.
21. Bonnefoy M., Jauffret M., Jusot J.F. Muscle power of lower extremities in relation to functional ability and nutritional status in very elderly people. J Nutr Health Aging 2007, 11:223-228.
22. Dargent-Molina P., Favier F., Grandjean H., Baudoin C., Schott A.M., Hausherr E., et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet 1996, 348:145-149.
23. Nguyen T., Sambrook P., Kelly P., Jones G., Lord S., Freund J., et al. Prediction of osteoporotic fractures by postural instability and bone density. BMJ 1993, 307:1111-1115.
24. Schwartz A.V., Nevitt M.C., Brown B.W., Kelsey J.L. Increased falling as a risk factor for fracture among older women: the study of osteoporotic fractures. Am J Epidemiol 2005, 161:180-185.
25. Gill T.M., Gahbauer E.A., Allore H.G., Han L. Transitions between frailty states among community-living older persons. Arch Intern Med 2006, 166:418-423.
26. Duque G., Mallet L., Roberts A., Gingrass S., Kremer R., Sainte-Marie L.G., et al. Quebec Symposium for the Treatment of Osteoporosis in Long-Term Care. To treat or not to treat, that is the question: proceedings of the Quebec Symposium for the Treatment of Osteoporosis in Long-term Care Institutions, Saint-Hyacinthe, Quebec, November 5, 2004. J Am Med Dir Assoc 2006, 7:435-441.